Search

Displaying results 6391 - 6400 of 10000 in total
  1. Drug

    Hyaluronidase (ovine)

    go.drugbank.com/drugs/DB00070
    Approved

    Highly purified sheep hyaluronidase for administration by injection into the vitreous of the eye.

  2. Drug

    Glesatinib

    go.drugbank.com/drugs/DB06302
    Investigational

  3. Drug

    Onalespib

    go.drugbank.com/drugs/DB06306
    Investigational

  4. Drug

    Avasimibe

    go.drugbank.com/drugs/DB06442
    Experimental

  5. Drug

    Levovirin

    go.drugbank.com/drugs/DB06523
    Experimental

  6. Drug

    TD101

    go.drugbank.com/drugs/DB06596
    Investigational

    TD101, a small interfering RNA (siRNA) designed for the treatment of pachyonychia congenita

  7. Drug

    Anamorelin

    go.drugbank.com/drugs/DB06645
    Investigational

  8. Drug

    TH0318

    go.drugbank.com/drugs/DB05145
    Experimental

    TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the treatment of type 2 diabetes.

  9. Drug

    Zansecimab

    go.drugbank.com/drugs/DB16389
    Investigational

    Zansecimab is under investigation in clinical trial NCT04342897 (A Study of LY3127804 in Participants With COVID-19).

  10. Drug

    Chlormadinone acetate

    go.drugbank.com/drugs/DB15903
    ApprovedWithdrawn

    Chlormadinone acetate is a progesterone derivative first synthesized in 1961. … However, the use of these drugs was associated with the development of mammary tumors in dogs. In 1972, the FDA withdrew its approval for the use of chlormadinone acetate in all products.